{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:39:33Z","timestamp":1790735973471,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,12,23]],"date-time":"2018-12-23T00:00:00Z","timestamp":1545523200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004948","name":"Astellas Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004948","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1111\/ajt.15225","type":"journal-article","created":{"date-parts":[[2018,12,24]],"date-time":"2018-12-24T00:59:26Z","timestamp":1545613166000},"page":"1730-1744","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Comparison of the effects of standard vs low-dose prolonged-release tacrolimus with or without ACEi\/ARB on the histology and function of renal allografts"],"prefix":"10.1016","volume":"19","author":[{"given":"Sandra M.","family":"Cockfield","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia M.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Cantarovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azim","family":"Gangji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Houde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony M.","family":"Jevnikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammy M.","family":"Keough-Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix-Mauricio","family":"Monroy-Cuadros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W.","family":"Nickerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel R.","family":"P\u00e2quet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.V.","family":"Ramesh Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne","family":"Sen\u00e9cal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Shoker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Howell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason J.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N.","family":"Rush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1111\/ajt.15225_bib1","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1600-6143.2010.03283.x","article-title":"Long-term renal allograft survival in the United States: a critical reappraisal","volume":"11","author":"Lamb","year":"2011","journal-title":"Am J Transplant."},{"issue":"1","key":"10.1111\/ajt.15225_bib2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/ndt\/gfq730","article-title":"Kidney allograft survival: the long and short of it","volume":"26","author":"Lodhi","year":"2011","journal-title":"J Lab Clin Med Nephrol Dial Transplant."},{"issue":"suppl 1","key":"10.1111\/ajt.15225_bib3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/ajt.14124","article-title":"OPTN\/SRTR 2015 annual data report: kidney","volume":"17","author":"Hart","year":"2017","journal-title":"Am J Transplant."},{"issue":"suppl 1","key":"10.1111\/ajt.15225_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2165\/00003495-200868001-00002","article-title":"Trends in kidney transplantation over the past decade","volume":"68","author":"Knoll","year":"2008","journal-title":"Drugs."},{"issue":"11","key":"10.1111\/ajt.15225_bib5","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1111\/j.1600-6143.2007.01979.x","article-title":"Lack of benefit of early protocol biopsies in renal transplant patients receiving TAC and MMF: a randomized study","volume":"7","author":"Rush","year":"2007","journal-title":"Am J Transplant."},{"issue":"4","key":"10.1111\/ajt.15225_bib6","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/01.tp.0000251807.72246.7d","article-title":"Comparison of low versus high tacrolimus levels in kidney transplantation: assessment of efficacy by protocol biopsies","volume":"83","author":"Cosio","year":"2007","journal-title":"Transplantation."},{"issue":"25","key":"10.1111\/ajt.15225_bib7","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1056\/NEJMoa067411","article-title":"Reduced exposure to calcineurin inhibitors in renal transplantation","volume":"357","author":"Ekberg","year":"2007","journal-title":"N Engl J Med."},{"issue":"8","key":"10.1111\/ajt.15225_bib8","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1111\/j.1600-6143.2009.02726.x","article-title":"Calcineurin inhibitor minimization in the SYMPHONY study: observational results 3 years after transplantation","volume":"9","author":"Ekberg","year":"2009","journal-title":"Am J Transplant."},{"issue":"suppl 1","key":"10.1111\/ajt.15225_bib9","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.2215\/CJN.00920207","article-title":"BK virus nephropathy and kidney transplantation","volume":"2","author":"Bohl","year":"2007","journal-title":"Clin J Am Soc Nephrol."},{"issue":"8","key":"10.1111\/ajt.15225_bib10","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1097\/TP.0000000000001243","article-title":"Calcineurin inhibitor nephrotoxicity through the lens of longitudinal histology: comparison of cyclosporine and tacrolimus eras","volume":"100","author":"Nankivell","year":"2016","journal-title":"Transplantation."},{"issue":"8","key":"10.1111\/ajt.15225_bib11","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/bjs.1800830813","article-title":"Early measurement of interstitial fibrosis predicts long-term renal function and graft survival in renal transplantation","volume":"83","author":"Nicholson","year":"1996","journal-title":"Br J Surg."},{"issue":"3","key":"10.1111\/ajt.15225_bib12","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1600-6143.2008.02519.x","article-title":"Identifying specific causes of kidney allograft loss","volume":"9","author":"El-Zoghby","year":"2009","journal-title":"Am J Transplant."},{"issue":"1","key":"10.1111\/ajt.15225_bib13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/TP.0b013e31823bb647","article-title":"Early subclinical rejection as a risk factor for late chronic humoral rejection","volume":"93","author":"Moreso","year":"2012","journal-title":"Transplantation."},{"issue":"1","key":"10.1111\/ajt.15225_bib14","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/TP.0b013e3181e065de","article-title":"Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure","volume":"90","author":"Gaston","year":"2010","journal-title":"Transplantation."},{"issue":"2","key":"10.1111\/ajt.15225_bib15","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1600-6143.2009.02954.x","article-title":"Pathological and clinical characterization of the \u201ctroubled transplant\u201d: data from the DeKAF study","volume":"10","author":"Gourishankar","year":"2010","journal-title":"Am J Transplant."},{"issue":"8","key":"10.1111\/ajt.15225_bib16","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1097\/TP.0000000000001244","article-title":"Calcineurin inhibitor nephrotoxicity in the era of antibody-mediated rejection","volume":"100","author":"Naesens","year":"2016","journal-title":"Transplantation."},{"issue":"5","key":"10.1111\/ajt.15225_bib17","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/j.1600-6143.2011.03911.x","article-title":"Kidney allograft inflammation and fibrosis, causes and consequences","volume":"12","author":"Gago","year":"2012","journal-title":"Am J Transplant."},{"issue":"6","key":"10.1111\/ajt.15225_bib18","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1097\/TP.0000000000001216","article-title":"Inflammation in early kidney allograft surveillance biopsies with and without associated tubulointerstitial chronic damage as a predictor of fibrosis progression & development of de novo donor specific antibodies","volume":"101","author":"Garc\u00eda-Carro","year":"2017","journal-title":"Transplantation."},{"key":"10.1111\/ajt.15225_bib19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1755-1536-7-15","article-title":"Recent advances in renal interstitial fibrosis and tubular atrophy after kidney transplantation","volume":"7","author":"Li","year":"2014","journal-title":"Fibrogenes Tissue Repair."},{"issue":"11","key":"10.1111\/ajt.15225_bib20","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1681\/ASN.2010010049","article-title":"Fibrosis with inflammation at one year predicts transplant functional decline","volume":"21","author":"Park","year":"2010","journal-title":"J Am Soc Nephrol."},{"key":"10.1111\/ajt.15225_bib21","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1681\/ASN.2017030287","article-title":"Class II eplet mismatch modulates tacrolimus trough levels required to prevent donor-specific antibody development","volume":"28","author":"Wiebe","year":"2017","journal-title":"J Am Soc Nephrol."},{"issue":"5","key":"10.1111\/ajt.15225_bib22","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/tri.12934","article-title":"Higher calcineurin inhibitor levels predict better kidney graft survival in patients with de novo donor-specific anti-HLA antibodies: a cohort study","volume":"30","author":"B\u00e9land","year":"2017","journal-title":"Transpl Int."},{"issue":"Suppl","key":"10.1111\/ajt.15225_bib23","first-page":"124","article-title":"De novo donor-specific antibody (DSA) is associated with decreased kidney graft survival and subclinical antibody-mediated rejection","volume":"10","author":"Nickerson","year":"2010","journal-title":"Am J Transpl."},{"issue":"5","key":"10.1111\/ajt.15225_bib24","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1681\/ASN.2016101066","article-title":"Immunologic effects of the renin-angiotensin system","volume":"28","author":"Crowley","year":"2017","journal-title":"J Am Soc Nephrol."},{"issue":"5","key":"10.1111\/ajt.15225_bib25","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0735-1097(03)00846-5","article-title":"Pleiotropic effects of angiotensin II receptor blocker in hypertensive patients","volume":"42","author":"Koh","year":"2003","journal-title":"J Am Coll Cardiol."},{"issue":"4","key":"10.1111\/ajt.15225_bib26","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/TP.0000000000001608","article-title":"Kidney fibrosis: origins and interventions","volume":"101","author":"Vanhove","year":"2017","journal-title":"Transplantation."},{"issue":"5","key":"10.1111\/ajt.15225_bib27","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000072820","article-title":"Effect of angiotensin II receptor blocker on plasma levels of TGF-beta 1 and interstitial fibrosis in hypertensive kidney transplant patients","volume":"23","author":"el-Agroudy","year":"2003","journal-title":"Am J Nephrol."},{"key":"10.1111\/ajt.15225_bib28","first-page":"139","article-title":"KDIGO clinical practice guideline for glomerulonephritis","volume":"2","year":"2012","journal-title":"Kidney Int Suppl."},{"issue":"3","key":"10.1111\/ajt.15225_bib29","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.tcm.2015.06.004","article-title":"Angiotensin receptor blockers: focus on cardiac and renal injury","volume":"26","author":"Arumugam","year":"2016","journal-title":"Trends Cardiovasc Med."},{"issue":"7","key":"10.1111\/ajt.15225_bib30","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1097\/TP.0b013e3181b723f4","article-title":"Factors associated with progression of interstitial fibrosis in renal transplant patients receiving tacrolimus and mycophenolate mofetil","volume":"88","author":"Rush","year":"2009","journal-title":"Transplantation."},{"issue":"4","key":"10.1111\/ajt.15225_bib31","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S2213-8587(15)00368-X","article-title":"Ramipril versus placebo in kidney transplant patients with proteinuria: a multicentre, double-blind, randomised controlled trial","volume":"4","author":"Knoll","year":"2016","journal-title":"LANCET Diabetes Endocrinol."},{"issue":"6","key":"10.1111\/ajt.15225_bib32","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1046\/j.1523-1755.2003.00318.x","article-title":"ACE inhibition limits chronic injury of kidney transplant even with treatment started when lesions are established","volume":"64","author":"Noris","year":"2003","journal-title":"Kidney Int."},{"issue":"2","key":"10.1111\/ajt.15225_bib33","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1681\/ASN.2012080777","article-title":"Angiotensin II blockade in kidney transplant recipients","volume":"24","author":"Ibrahim","year":"2013","journal-title":"J Am Soc Nephrol."},{"issue":"6","key":"10.1111\/ajt.15225_bib34","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/TP.0b013e3182827a43","article-title":"Effects of ACE inhibitors on long-term outcome of renal transplant recipients: a randomized controlled trial","volume":"95","author":"Paoletti","year":"2013","journal-title":"Transplantation."},{"issue":"1","key":"10.1111\/ajt.15225_bib35","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1053\/j.ajkd.2016.08.018","article-title":"Renin-angiotensin system blockade and long-term clinical outcomes in kidney transplant recipients: a meta-analysis of randomized controlled trials","volume":"69","author":"Hiremath","year":"2017","journal-title":"Am J Kidney Dis."},{"key":"10.1111\/ajt.15225_bib36","unstructured":"Astellas Pharma Canada I. Advagraf Product Monograph. https:\/\/www.astellas.ca\/Uploads\/pdf\/2015-07-31%20Advagraf%20PM-Approved.pdf Accessed January 11, 2019."},{"key":"10.1111\/ajt.15225_bib37","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1600-6143.2008.02159.x","article-title":"Banff 07 classification of renal allograft pathology: updates and future directions","volume":"8","author":"Solez","year":"2008","journal-title":"Am J Transplant."},{"issue":"5","key":"10.1111\/ajt.15225_bib38","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1111\/j.1600-6143.2005.00811.x","article-title":"Kidney allograft fibrosis and atrophy early after living donor transplantation","volume":"5","author":"Cosio","year":"2005","journal-title":"Am J Transplant."},{"issue":"9","key":"10.1111\/ajt.15225_bib39","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1111\/ajt.12370","article-title":"Kidney allograft survival after acute rejection, the value of follow-up biopsies","volume":"13","author":"El Ters","year":"2013","journal-title":"Am J Transplant."},{"issue":"11","key":"10.1111\/ajt.15225_bib40","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1111\/ajt.13347","article-title":"Rates and determinants of progression to graft failure in kidney allograft recipients with de novo donor-specific antibody","volume":"15","author":"Wiebe","year":"2015","journal-title":"Am J Transplant."},{"issue":"8","key":"10.1111\/ajt.15225_bib41","doi-asserted-by":"crossref","first-page":"e0159717","DOI":"10.1371\/journal.pone.0159717","article-title":"Decreased kidney graft survival in low immunological risk patients showing inflammation in normal protocol biopsies","volume":"11","author":"Ortiz","year":"2016","journal-title":"PLoS ONE."},{"issue":"8","key":"10.1111\/ajt.15225_bib42","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1097\/TP.0000000000001163","article-title":"Subclinical rejection in renal transplantation: reappraised","volume":"100","author":"Mehta","year":"2016","journal-title":"Transplantation."},{"issue":"1","key":"10.1111\/ajt.15225_bib43","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/kisup.2014.14","article-title":"Fibrosis and renal aging","volume":"4","author":"Yang","year":"2014","journal-title":"Kidney Int Suppl."},{"issue":"2","key":"10.1111\/ajt.15225_bib44","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2215\/CJN.04800908","article-title":"Calcineurin inhibitor nephrotoxicity","volume":"4","author":"Naesens","year":"2009","journal-title":"Clin J Am Soc Nephrol."},{"issue":"4","key":"10.1111\/ajt.15225_bib45","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1600-6143.2011.03505.x","article-title":"Chronic progressive calcineurin nephrotoxicity: an overstated concept","volume":"11","author":"Matas","year":"2011","journal-title":"Am J Transplant."},{"issue":"11","key":"10.1111\/ajt.15225_bib46","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1097\/TP.0000000000001333","article-title":"BK polyomavirus and the transplanted kidney: immunopathology and therapeutic approaches","volume":"100","author":"Lamarche","year":"2016","journal-title":"Transplantation."},{"issue":"11","key":"10.1111\/ajt.15225_bib47","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1111\/ajt.13946","article-title":"Failure of calcineurin inhibitor (tacrolimus) weaning randomized trial in long-term stable kidney transplant recipients","volume":"16","author":"Dugast","year":"2016","journal-title":"Am J Transplant."},{"issue":"5","key":"10.1111\/ajt.15225_bib48","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1111\/ajt.14109","article-title":"Reduction of extended-release tacrolimus dose in low-immunological-risk kidney transplant recipients increases risk of rejection and appearance of donor-specific antibodies: a randomized study","volume":"17","author":"Gatault","year":"2017","journal-title":"Am J Transplant."},{"issue":"10","key":"10.1111\/ajt.15225_bib49","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/tri.12155","article-title":"Tacrolimus trough levels after month 3 as a predictor of acute rejection following kidney transplantation: a lesson learned from DeKAF genomics","volume":"26","author":"Israni","year":"2013","journal-title":"Transpl Int."},{"issue":"9","key":"10.1111\/ajt.15225_bib50","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1097\/TP.0b013e3181a23cb2","article-title":"The challenge of achieving target drug concentrations in clinical trials: experience from the SYMPHONY study","volume":"87","author":"Ekberg","year":"2009","journal-title":"Transplantation."},{"issue":"7","key":"10.1111\/ajt.15225_bib51","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1097\/01.tp.0000258589.39006.94","article-title":"Influence of angiotensin II on expression of Toll-like receptor 2 and maturation of dendritic cells in chronic cyclosporine nephropathy","volume":"83","author":"Ahn","year":"2007","journal-title":"Transplantation."},{"issue":"suppl","key":"10.1111\/ajt.15225_bib52","first-page":"614","article-title":"Angiotensin converting enzyme (ACE) over-expression in mouse macrophages up-regulates iNOS and markedly increases resistance to listeria and MRSA","volume":"25","author":"Okwan-Doudu","year":"2011","journal-title":"FASEB J."},{"key":"10.1111\/ajt.15225_bib53","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/0014-5793(94)00531-1","article-title":"Activation of human peripheral monocytes by angiotensin II","volume":"347","author":"Hahn","year":"1994","journal-title":"FEBS Lett."},{"key":"10.1111\/ajt.15225_bib54","first-page":"112","article-title":"Effects of losartan treatment on T-cell activities and plasma leptin concentrations in primary hypertension","volume":"2","author":"Sonmez","year":"2001","journal-title":"JRAAS."},{"issue":"24","key":"10.1111\/ajt.15225_bib55","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1161\/01.CIR.0000143085.86697.13","article-title":"Additive beneficial effects of losartan combined with simvastatin in the treatment of hypercholesterolemic, hypertensive patients","volume":"110","author":"Kwang","year":"2004","journal-title":"Circulation."},{"issue":"10","key":"10.1111\/ajt.15225_bib56","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.intimp.2009.06.006","article-title":"Immunosuppressive effect of angiotensin receptor blocker on stimulation of mice CTLs by angiotensin II","volume":"9","author":"Maeda","year":"2009","journal-title":"Int Immunopharmacol."},{"issue":"4","key":"10.1111\/ajt.15225_bib57","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1681\/ASN.V124822","article-title":"Effects of losartan and amlodipine on intrarenal hemodynamics and TGF-beta(1) plasma levels in a crossover trial in renal transplant recipients","volume":"12","author":"I\u00f1igo","year":"2001","journal-title":"J Am Soc Nephrol."},{"issue":"9","key":"10.1111\/ajt.15225_bib58","first-page":"540","article-title":"Molecular and clinical response to angiotensin II receptor antagonist in kidney transplant patients with chronic allograft nephropathy","volume":"17","author":"Mas","year":"2004","journal-title":"Transpl Int."},{"issue":"12","key":"10.1111\/ajt.15225_bib59","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1172\/JCI7451","article-title":"Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway","volume":"104","author":"Nataraj","year":"1999","journal-title":"J Clin Invest."},{"issue":"suppl","key":"10.1111\/ajt.15225_bib60","first-page":"208","article-title":"Lower mean tacrolimus troughs increase risk of de novo donor-specific antibodies in the first year of kidney transplant","volume":"17","author":"Davis","year":"2017","journal-title":"Am J Transpl."}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.15225","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.15225","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ajt.15225","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522091171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522091171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.15225","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:25:02Z","timestamp":1761629102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522091171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":60,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S1600613522091171"],"URL":"https:\/\/doi.org\/10.1111\/ajt.15225","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of the effects of standard vs low-dose prolonged-release tacrolimus with or without ACEi\/ARB on the histology and function of renal allografts","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.15225","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc.Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}